🔎 Trials Near Me

Почетна › Dijabetes tipa 2 › Alabama

Kliničke studije za Dijabetes tipa 2 u državi Alabama

22 studija za Dijabetes tipa 2 traži učesnike na lokacijama u državi Alabama.

Gradovi u državi Alabama

Zvanični tekst studije (na engleskom)

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

  • Cahaba Research, Inc. - Trussville Location, Birmingham
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07754461

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Pinnacle Research Group, LLC, Anniston
  • Eastern Shore Research Group, Fairhope
  • Lakeview Clinical Research, Guntersville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07064473

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Lakeview Clinical Research, Guntersville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351058

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Birmingham Clinical Research, Birmingham
  • Cullman Clinical Trials, Cullman
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07282600

A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)

  • Central Alabama Research, Birmingham
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07915609

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Heart Center Research, LLC, Huntsville
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07783802

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

  • Research Site, Huntsville
  • Research Site, Mobile
  • Research Site, Sheffield
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07662109

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Fairhope
  • Research Site, Huntsville
  • Research Site, Mobile
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07784270

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  • Apogee Clinical Research, LLC, Huntsville
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 27. 10. 2026. · NCT07271186

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

  • Research Site, Birmingham
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07662213

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

  • Central Research Associates, LLC dba Flourish Research, Birmingham
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 20. 10. 2026. · NCT07502508

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

  • Flourish Research, Birmingham
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 7. 10. 2026. · NCT07668388

Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)

  • UAB Highlands Hospital/Department of Family and Community Medicine, Birmingham
Тражи се учесник
Узраст од 18 до 89 · Оба пола · Ажурирано 6. 10. 2026. · NCT07032844

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

  • University of Alabama, Birmingham
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT06906627

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

  • University of Alabama, Birmingham
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT06906640

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Birmingham
  • AURORA-2 Clinical Site, Huntsville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT07743450

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

  • Univ of Alabama Birmingham, Birmingham
  • Eastern Shore Rsrch Inst, LLC, Fairhope
  • Chambliss Clinical Trials, LLC, Montgomery
Тражи се учесникФаза 3
Узраст 45 и старији · Оба пола · Ажурирано 1. 9. 2026. · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

  • Research Site, Birmingham
  • Research Site, Daphne
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 31. 8. 2026. · NCT07662044

CGM for Management of Type 2 Diabetes in Pregnancy

  • University of Alabama at Birmingham, Birmingham
Тражи се учесник
Узраст од 18 до 50 · Жене · Ажурирано 29. 6. 2026. · NCT06628453

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

  • University of Alabama at Birmingham, Birmingham
Тражи се учесникОпсервациона студија
Узраст од 8 до 15 · Оба пола · Ажурирано 7. 5. 2026. · NCT06525259

FELLAShip to Better Health

  • The Worship Center Cristian Church, Birmingham
Тражи се учесник
Узраст 18 и старији · Мушкарци · Ажурирано 22. 1. 2026. · NCT07220213

A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients

  • University of Alabama at Birmingham/ Children's of Alabama, Birmingham
Тражи се учесник
Узраст од 12 до 18 · Оба пола · Ажурирано 8. 12. 2025. · NCT06902077

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.